Literature DB >> 17962058

Successful treatment of niclosamide- and praziquantel-resistant beef tapeworm infection with nitazoxanide.

Mohammad Lateef1, Showkat Ali Zargar, Abdul Rashid Khan, Muzzaffar Nazir, Abid Shoukat.   

Abstract

BACKGROUND: Beef tapeworm (Taenia saginata) infection is acquired by eating inadequately cooked beef that contains the larvae or cysticerci of T. saginata. Niclosamide and praziquantel have proved effective for its treatment but treatment failures are well known. We report herein the results of nitazoxanide therapy.
METHODS: A prospective study was conducted in 18 children and 34 adults to assess the efficacy and safety of nitazoxanide in the treatment of niclosamide- and praziquantel-resistant T. saginata infection. Nitazoxanide was administered twice daily for 3 days in 500-mg doses for those aged over 14 years and at 20mg/kg body weight/day in children aged 5-14 years. Post-treatment follow-up was undertaken at 1, 2, 4, 8, and 12 weeks for fecal samples for proglottides, and to check the presence, number, and viability of Taenia eggs.
RESULTS: Nitazoxanide cured 51 of 52 (98.1%) patients. Mild side effects occurred in seven patients, which resolved spontaneously. There were no abnormalities in laboratory parameters.
CONCLUSIONS: Nitazoxanide is a safe, effective, inexpensive, and well-tolerated drug for the treatment of niclosamide- and praziquantel-resistant beef tapeworm infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962058     DOI: 10.1016/j.ijid.2007.04.017

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  12 in total

1.  Thiazolides promote G1 cell cycle arrest in colorectal cancer cells by targeting the mitochondrial respiratory chain.

Authors:  P Ripani; J Delp; K Bode; M E Delgado; L Dietrich; V M Betzler; N Yan; G von Scheven; T U Mayer; M Leist; T Brunner
Journal:  Oncogene       Date:  2019-12-16       Impact factor: 9.867

Review 2.  Antiparasitic therapy.

Authors:  Shanthi Kappagoda; Upinder Singh; Brian G Blackburn
Journal:  Mayo Clin Proc       Date:  2011-06       Impact factor: 7.616

Review 3.  Neurocysticercosis: a review on status in India, management, and current therapeutic interventions.

Authors:  Rumana Ahmad; Tahmeena Khan; Bilal Ahmad; Aparna Misra; Anil K Balapure
Journal:  Parasitol Res       Date:  2016-10-24       Impact factor: 2.289

4.  JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.

Authors:  Tomoyuki Yoshikawa; Morikazu Miyamoto; Tadashi Aoyama; Hiroaki Soyama; Tomoko Goto; Junko Hirata; Ayako Suzuki; Isao Nagaoka; Hitoshi Tsuda; Kenichi Furuya; Masashi Takano
Journal:  Oncol Lett       Date:  2018-02-12       Impact factor: 2.967

5.  Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer.

Authors:  Shuo You; Rui Li; Dongkyoo Park; Maohua Xie; Gabriel L Sica; Ya Cao; Zhi-Qiang Xiao; Xingming Deng
Journal:  Mol Cancer Ther       Date:  2013-12-20       Impact factor: 6.261

6.  Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer.

Authors:  Rui Li; Zhongliang Hu; Shi-Yong Sun; Zhuo G Chen; Taofeek K Owonikoko; Gabriel L Sica; Suresh S Ramalingam; Walter J Curran; Fadlo R Khuri; Xingming Deng
Journal:  Mol Cancer Ther       Date:  2013-07-26       Impact factor: 6.261

Review 7.  Zoonotic helminth infections with particular emphasis on fasciolosis and other trematodiases.

Authors:  Mark W Robinson; John P Dalton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-09-27       Impact factor: 6.237

Review 8.  Repurposing drugs for the treatment and control of helminth infections.

Authors:  Gordana Panic; Urs Duthaler; Benjamin Speich; Jennifer Keiser
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-07-30       Impact factor: 4.077

9.  Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis.

Authors:  Karen K Y Lam; Xingji Zheng; Roberto Forestieri; Aruna D Balgi; Matt Nodwell; Sarah Vollett; Hilary J Anderson; Raymond J Andersen; Yossef Av-Gay; Michel Roberge
Journal:  PLoS Pathog       Date:  2012-05-10       Impact factor: 6.823

Review 10.  Praziquantel treatment in trematode and cestode infections: an update.

Authors:  Jong-Yil Chai
Journal:  Infect Chemother       Date:  2013-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.